旭化成メディカル
  • サイトマップ
  • お問い合わせ
  • 文字サイズ小
  • 文字サイズ中
  • 文字サイズ大
  • ホーム
  • 私たちの取り組み
  • ニュース
  • 製品紹介
  • 会社案内
  • 医療・製薬関係者の皆さま
  • 患者さま・ご家族の皆さま

セルソーバE 潰瘍性大腸炎治療のスタンダードへ 医療従事者向けサイト

セルソーバEの文献をご紹介しています。

ピックアップ文献

Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column.
Sawada K,Muto T,Hibi T,et al.
Curr Pharm Des 9(4):307-21,2003

文献一覧

1)潰瘍性大腸炎治療に期待されるフィルター法白血球除去療法.
杉憲侑.
BIO Clinica 12(5):339-42,1997
2)Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column.
Sawada K,Muto T,Hibi T,et al.
Curr Pharm Des 9(4):307-21,2003
3)Leukocytapheresis in Ulcerative Colitis:Results of a Multicenter Double-Blind Prospective Case-Control Study with Sham Apheresis as Placebo Treatment.
Sawada K,Kusugami K,Shimoyama T,et al.
Am J Gastroenterol 100(6):1362-9,2005
4)IBDに対する白血球除去フィルターによるleucocytapheresisの経過報告.
澤田康史,大西国夫.下山孝,他.
厚生省特定疾患難治性炎症性腸管障害調査研究班 平成5年度研究報告書:238-40,1994
5) Prospective Open Multicenter Trial of Leukocytapheresis in Pediatric Ulcerative Colitis Patients.
Tomomasa T,Tajiri H,Kobayashi A,et al.
J Pediatr Gastroenterol Nutr 53:34-9,2011
6)炎症性腸疾患の白血球除去療法.
澤田康史,大西国夫,下山孝,他.
内科77(2):287-92,1996
7)Leukocyte Removal Fiter-Passed Lymphocytes Produce Large Amounts of interleukin‐4 in Immunotherapy for Inflammatory Bowel Disease:Role of Bystander Suppression.
Noguchi M,Hiwatashi N,Toyota T,et al.
Therapeutic Apheresis 2(2):109-14,1998
8)Suppression of interleukin-1β-and tumor necrosis factor-α-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis.
Andoh A,Ogawa A,Fujyama Y,et al.
J Gastroenterol 39(12):1150-7,2004
9)Diminished cytokine signalling against bacterial components in mononuclear leukocytes from ulcerative colitis patients after leukocytapheresis.
Mitsuyama K,Suzuki A,Sata M,et al.
Clin Exp lmmunol 141(1):130-40,2005
10)Decrease of reactive- oxygen-producing granulocytes and release of lL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.
Hanai H,Iida T,Takai K,et al.
World J Gastroenterol 11(20):3085-90,2005
11)Leukocytapheresis Therapy Modulates Circulating T cell Subsets in Patients with Ulcerative Colitis.
Andoh A,Tsujikawa T,Fujiyama Y,et al.
Ther Apher Dial 9(3):270-6,2005
12)Extracoporeal Elimination of TNF-α-Producing CD14dull CD16+ Monocytes in Leukocytapheresis Therapy for Ulcerative Colitis.
Kanai T,Makita S,Watanabe M,et al.
Inflamm Bowel Dis 13(3):284-90,2007
13)Activated Platelets in Ulcerative Colitis Enhance the Production of Reactive Oxygen Species by Polymorphonuclear Leukocytes.
Suzuki K,Sugimura K,Asakura H,et al.
Scand J Gastroenterol 36(12):1301-6,2001
14) Activeated platelet as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients.
Fukunaga K,Fukuda Y,Matsumoto T,et al.
J Gastroenterol 41(6):524-32,2006
15)Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis.
Yagi Y,Andoh A,Yoshida T,et al.
J Gastroenterol 41(6):540-6,2006
16) Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis.
Mitsuyama K,Andoh A,Masuda J,et al.
Ther Apher Dial 12:271-7,2008
17)A Pilot Study of Leukocytapheresis Efficacy With 1.5 Liter Blood Processing Volume in Patients With Ulcerative Colitis.
Shimada M, et al.
Therapeutic Apheresis and Dialysis 12(5): 368-373, 2008
18)Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with cellsorba in patients with active ulcerative colitis.
Fukunaga K, et al.
J Clin Apher 26(6) :326-31,2011
19)A New Paradigm in Ulcerative Colitis: Regulatory T Cells are Key Factor which Induces/Exacerbates UC through an Immune Imbalance Molecular Immunology
Hanai H., Iida T., Ikeya K., et al.
Mol Immunol 54 :173–180,2013
20)Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis
Okuyama Y., Andoh A., Nishishita M., et al.
Scand J Gastroenterol. ,2013 Jan 28. [Epub ahead of print]
21)Microarray analyses of peripheral whole blood cells from ulcerative colitis patients: Effects of leukocytapheresis
Kobayashi T, Mitsuyama K, Yamasaki H, et al.
Int J Mol Med. 31(4):789-96,2013 Apr

その他の文献について

以下よりその他のアフェレシス治療に関連する文献情報をご覧いただけます。

文献情報

特集

潰瘍性大腸炎患者847例を対象としたセルソーバE(白血球除去療法、LCAP)の使用成績調査の結果をご報告致します。

お問い合わせ

製品やサポートに関するご質問などお気軽にお問い合わせください。

お問い合わせ

ページの先頭に戻る